(Q42683586)
Statements
1 reference
Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial (English)
1 reference
Haya Ascher-Svanum
1 reference
Sandra L Tunis
1 reference
Douglas E Faries
1 reference
Allen W Nyhuis
1 reference
Bruce J Kinon
1 reference
Ralph Aquila
1 reference
1 March 2006
1 reference
1 reference
9
1 reference
2
1 reference
77-89
1 reference
Identifiers
1 reference
1 reference